8436 results
-
List item
Human medicine European public assessment report (EPAR): Elonva (updated)
corifollitropin alfa, Reproductive Techniques, Assisted Ovulation Induction
Date of authorisation: 25/01/2010, Revision: 14, Authorised -
List item
Human medicine European public assessment report (EPAR): Darunavir Krka (updated)
darunavir, HIV Infections
Date of authorisation: 26/01/2018, Generic, Revision: 2, Authorised -
List item
Human medicine European public assessment report (EPAR): Rapamune (updated)
sirolimus, Graft Rejection Kidney Transplantation
Date of authorisation: 13/03/2001, Revision: 38, Authorised -
List item
Veterinary medicine European public assessment report (EPAR): Galliprant (updated)
grapiprant, Dogs
Date of authorisation: 09/01/2018, Revision: 2, Authorised -
List item
Human medicine European public assessment report (EPAR): Tecfidera (updated)
dimethyl fumarate, Multiple Sclerosis
Date of authorisation: 30/01/2014, Revision: 13, Authorised -
List item
Human medicine European public assessment report (EPAR): Rituzena (previously Tuxella) (updated)
rituximab, Lymphoma, Non-Hodgkin Microscopic Polyangiitis Leukemia, Lymphocytic, Chronic, B-Cell Wegener Granulomatosis
Date of authorisation: 13/07/2017, Additional monitoring, Biosimilar, Revision: 6, Authorised -
List item
Human medicine European public assessment report (EPAR): Actelsar HCT (updated)
telmisartan / hydrochlorothiazide,
Date of authorisation: 13/03/2013, Generic, Revision: 9, Authorised -
List item
Human medicine European public assessment report (EPAR): Prevenar 13 (updated)
pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed), Pneumococcal Infections Immunization
Date of authorisation: 09/12/2009, Revision: 32, Authorised -
List item
Human medicine European public assessment report (EPAR): Integrilin (updated)
eptifibatide, Angina, Unstable Myocardial Infarction
Date of authorisation: 01/07/1999, Revision: 22, Authorised -
List item
Human medicine European public assessment report (EPAR): BeneFIX (updated)
nonacog alfa, Hemophilia B
Date of authorisation: 27/08/1997, Revision: 38, Authorised -
List item
Human medicine European public assessment report (EPAR): Panretin (updated)
alitretinoin, Sarcoma, Kaposi
Date of authorisation: 11/10/2000, Revision: 16, Authorised -
List item
Human medicine European public assessment report (EPAR): Aldara (updated)
imiquimod, Condylomata Acuminata Keratosis Keratosis, Actinic Carcinoma, Basal Cell
Date of authorisation: 18/09/1998, Revision: 25, Authorised -
List item
Human medicine European public assessment report (EPAR): Levetiracetam Hospira (updated)
levetiracetam, Epilepsy
Date of authorisation: 07/01/2014, Generic, Revision: 9, Authorised -
List item
Human medicine European public assessment report (EPAR): Cyanokit (updated)
hydroxocobalamin, Poisoning
Date of authorisation: 23/11/2007, Revision: 10, Authorised -
List item
Veterinary medicine European public assessment report (EPAR): Pirsue (updated)
pirlimycin, Cattle
Date of authorisation: 29/01/2001, Revision: 14, Authorised -
List item
Human medicine European public assessment report (EPAR): Daptomycin Hospira (updated)
daptomycin, Soft Tissue Infections Skin Diseases, Bacterial
Date of authorisation: 22/03/2017, Generic, Revision: 4, Authorised -
List item
Human medicine European public assessment report (EPAR): Valdoxan (updated)
Agomelatine, Depressive Disorder, Major
Date of authorisation: 19/02/2009, Revision: 19, Authorised -
List item
Human medicine European public assessment report (EPAR): Pandemic Influenza Vaccine H5N1 Baxter AG (updated)
pandemic influenza vaccine (H5N1) (whole virion, inactivated, prepared in cell culture), Influenza, Human Immunization Disease Outbreaks
Date of authorisation: 12/12/2018, Exceptional circumstances, Revision: 6, Authorised -
List item
Human medicine European public assessment report (EPAR): Foclivia (updated)
pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted), Influenza, Human Immunization Disease Outbreaks
Date of authorisation: 18/10/2009, Exceptional circumstances, Revision: 6, Authorised -
List item
Human medicine European public assessment report (EPAR): Lamivudine Teva Pharma B.V. (updated)
lamivudine, HIV Infections
Date of authorisation: 10/12/2009, Generic, Revision: 13, Authorised -
List item
Human medicine European public assessment report (EPAR): Nimenrix (updated)
meningococcal group A, C, W 135 and Y conjugate vaccine, Meningitis, Meningococcal
Date of authorisation: 20/04/2012, Revision: 24, Authorised -
List item
Human medicine European public assessment report (EPAR): Atazanavir Mylan (updated)
atazanavir, HIV Infections
Date of authorisation: 22/08/2016, Generic, Revision: 5, Authorised -
List item
Human medicine European public assessment report (EPAR): Efient (updated)
prasugrel, Acute Coronary Syndrome Angina, Unstable Myocardial Infarction
Date of authorisation: 24/02/2009, Revision: 16, Authorised -
List item
Human medicine European public assessment report (EPAR): Halaven (updated)
eribulin, Breast Neoplasms Liposarcoma
Date of authorisation: 17/03/2011, Revision: 18, Authorised -
List item
Human medicine European public assessment report (EPAR): Imnovid (previously Pomalidomide Celgene) (updated)
pomalidomide, Multiple Myeloma
Date of authorisation: 04/08/2013, Additional monitoring, Revision: 14, Authorised